| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other expense, net | -1,049 | -809 | -740 | -1,007 |
| Loss before income tax expense | -8,603 | -9,890 | -11,212 | - |
| Income tax expense | - | 33 | 52 | - |
| Net loss | -8,603 | -9,923 | -11,264 | -10,372 |
| Foreign currency translation adjustment | -2 | 2 | 1 | 51 |
| Comprehensive loss | -8,605 | -9,921 | -11,263 | -10,321 |
| Earnings per share, basic | -0.19 | -0.22 | -0.25 | -0.42 |
| Earnings per share, diluted | -0.19 | -0.22 | -0.25 | -0.42 |
| Weighted average number of shares outstanding, basic | 45,421,795 | 45,365,325 | 45,267,020 | 24,703,578 |
| Weighted average number of shares outstanding, diluted | 45,421,795 | 45,365,325 | 45,267,020 | 24,703,578 |
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)